Russia Oncology Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : February 2022
  • Region: Russia
  • Country: Other
  • Report ID : 5073

  • Format: PPT, PDF

Russia Oncology Drugs Market: Segmented by Cancer Type and Application Type, and Dosage Form – Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2028

SKU: 5073 Categories: ,

Report Description of the Russia Oncology Drugs Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of Russia Oncology Drugs Drugs market
  • To classify and forecast Russia Oncology Drugs Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for Russia Oncology Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Russia Oncology Drugs market
  • To conduct pricing analysis for Russia Oncology Drugs Drugs market
  • To identify and analyze the profile of leading players operating in Russia Oncology Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Russia Oncology Drugs Market Executive Summary

In Russia the accumulated risk of developing cancer by the age of 75 was 24.7% (29.4% were men and 22.3% – women). By the end of 2014, registered in cancer care facilities were 3.29 million patients which is responsible for this phenomenon and consequently leading to the growth of the market.

Market Size and Key Findings

The Russia Oncology Drugs market size is at around USD xx billion in 2021 and is projected to reach USD xx billion in 2028, exhibiting a CAGR of xx% during the forecast period.

In Russia, there are annually about 2 million cancer patients in need of palliative care that is inaccessible (for drug-related regulatory reasons) for a great number of patients. In terms of five-year survival rate, in 2014 only 52.4% of cancer patients could overcome the five-year period after first being diagnosed. Therefore, the increasing need of cancer treatment is expected to boost the demand for the global oncology cancer drugs market during the forecast period.

Market Dynamics

Market Growth Drivers Analysis

Surge in incidence of cancer across the globe, increase in aging population, and, surge in number of pipeline drugs and untapped potential in emerging geographies create new opportunities in the market.

Market Restraints

Adverse effects related to usage of cancer drugs hinder the market growth. negatively influencing the growth of the market.

Competitive Landscape

Key Players

Key market players include Biocade, Roche, Bristol-Myers Squibb, Veropharm (Abbott), MSD, Sanofi, Novartis, Pfizer, Eisai, Celgene, Amgen, Nativa, Merck KGaA, AstraZeneca, Johnson & Johnson, Eli Lilly, Takeda, Bayer, Sandoz, Blokhin Cancer Research centre

Products in Pipeline

Positive results demonstrating an overall survival (OS) benefit from the Phase 3 trial investigating Sanofi and Regeneron’s PD-1 inhibitor Libtayo® (cemiplimab) monotherapy compared to chemotherapy in patients previously treated with chemotherapy whose cervical cancer is recurrent or metastatic. Libtayo monotherapy is the first medicine to demonstrate an improvement in overall survival in women with recurrent or metastatic cervical cancer following progression on platinum-based chemotherapy in a Phase 3 trial.

Notable Recent Deals

September 17, 2021: Oasmia Pharmaceutical AB, an oncology-focused specialty pharmaceutical company, announces that it has signed a license agreement with the Swiss-based FarmaMondo Group for the commercialization of Paclical® (Apealea®) in Russia and the Commonwealth of Independent States.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of Russia Oncology Drugs Services

In 2011, 5 targeted cancer therapies were covered in the essential drug list (Bevacizumab, Rituximab, Trastuzumab, Imatinib and Bortezomib). In 2012, an additional 8 branded cancer drugs were added to the list, expanding the coverage of targeted cancer therapies to 13 products. The price change trend for selected analogs show some products covered at the same price, while for others price was reduced by 5-10%. For example, one of the covered monoclonal antibodies price did not change during 2011 and 2012, while prices for a proteasome inhibitor and a tyrosine kinase inhibitor were lowered by 6% and 10%, respectively.

1. Report Description of the Russia Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Russia Oncology Drugs Market Executive Summary
2.1 Russia Oncology Drugs Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Russia Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.1.1 Surge in incidence of cancer
3.1.2 Increase in aging population
3.1.3 Surge in number of pipeline drugs
3.1.4 Untapped potential in emerging geographies
3.2 Market Restraints Analysis
3.3 Adverse effects related to usage of cancer drugs
4. Oncology Drugs Market Segmentation
4.1 By Drug Class Analysis:
4.1.1 Cytotoxic Drugs
4.1.2 Targeted Drugs
4.1.3 Hormonal Drugs
4.2 By Cancer Type Analysis:
4.2.1 Breast Cancer
4.2.2 Gastrointestinal Cancer
4.2.3 Blood Cancer
4.2.4 Bladder Cancer
4.2.5 Liver Cancer
4.2.6 Lung and Bronchus Cancer
4.2.7 Skin Cancer
4.2.8 Others
4.3 By Application Type Analysis:
4.3.1 Immunotherapy
4.3.2 Targeted Therapy
4.3.3 Hormone Therapy
4.3.4 Chemotherapy
4.4 By Dosage Form Analysis:
4.4.1 Solid
4.4.2 Liquid
4.4.3 Injectable
5. Russia Oncology Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Russia Oncology Drugs Market
6.4 Notable recent deals in Russia Oncology Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Biocade Company Overview
Product & Services, Strategies & Financials
7.2 Roche Company Overview
Product & Services, Strategies & Financials
7.3 Bristol-Myers Squibb Company Overview
Product & Services, Strategies & Financials
7.4 Veropharm (Abbott) Company Overview
Product & Services, Strategies & Financials
7.5 MSD Company Overview
Product & Services, Strategies & Financials
7.6 Sanofi Company Overview
Product & Services, Strategies & Financials
7.7 Novartis, Company Overview
Product & Services, Strategies & Financials
7.8 Takeda Company Overview
Product & Services, Strategies & Financials
7.9 Bayer Company Overview
Product & Services, Strategies & Financials
7.10 Sandoz Company Overview
Product & Services, Strategies & Financials
7.11 Novartis Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of Russia Oncology Drugs Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development Russia Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations

Oncology Drugs Market Segmentation

By Cancer Type:

In 2018, over 90 thousand malignant skin tumors, including melanomas, were diagnosed in Russia. Breast cancer was the second most popular type of the disease in the country, consequently drive the growth of the oncology drug market in Russia

  • Breast Cancer
  • Gastrointestinal Cancer
  • Blood Cancer
  • Bladder Cancer
  • Liver Cancer
  • Lung and Bronchus Cancer
  • Skin Cancer
  • Others

By Application Type:

The targeted drugs are expected to dominate the global market. The chemotherapy or targeted therapy is aimed at the disease while minimizing the off-target side-effects caused to the normal cells.

  • Immunotherapy
  • Targeted Therapy
  • Hormone Therapy
  • Chemotherapy

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements